William Blair upgraded shares of Cott (TSE:PRM – Free Report) to a strong-buy rating in a research report released on Thursday morning, Zacks.com reports.
Separately, Raymond James lowered Cott from a “moderate buy” rating to a “hold” rating in a research report on Wednesday, October 2nd.
Read Our Latest Research Report on Cott
Cott Trading Down 1.4 %
Cott Dividend Announcement
The company also recently announced a None dividend, which will be paid on Thursday, November 21st. Investors of record on Tuesday, November 5th will be given a $1.109 dividend. The ex-dividend date is Tuesday, November 5th.
About Cott
Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.
Featured Stories
- Five stocks we like better than Cott
- How to Invest in the FAANG Stocks
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
- Insider Buying Explained: What Investors Need to Know
- The Downtrend in UPS Stock Isn’t Over Yet
- What is a Low P/E Ratio and What Does it Tell Investors?
- Maximize Portfolio Income with These 3 Dividend ETFs
Receive News & Ratings for Cott Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cott and related companies with MarketBeat.com's FREE daily email newsletter.
